Literature DB >> 21965374

Cardiovascular effects of dexmedetomidine sedation in children.

Jackson Wong1, Garry M Steil, Michelle Curtis, Alexandra Papas, David Zurakowski, Keira P Mason.   

Abstract

BACKGROUND: Dexmedetomidine (DEX) affects heart rate (HR), mean arterial blood pressure, cardiac index (CI), stroke index (SI), and systemic vascular resistance index (SVRI) in adults. In this study we sought to determine whether similar effects occur in children undergoing DEX sedation.
METHODS: Hemodynamic changes in children were followed during IV DEX sedation for radiological procedures. One group of 8 patients (DEX-brief) received a bolus (2 mcg/kg bolus over 10 minutes) and completed the procedure within 10 minutes. The second group of 9 patients (DEX-prolong) received the bolus plus additional DEX as needed to maintain sedation for procedures lasting longer than 10 minutes (additional 1 mcg/kg/hr infusion with second bolus if needed). CI, SI, and SVRI were measured using a continuous noninvasive cardiac output monitor. Changes in hemodynamic variables at minutes 10, 20, and discharge (time at which patient achieved Aldrete Score ≥9) were compared to baseline by repeated measures ANOVA with effect sizes reported as mean [95% confidence interval].
RESULTS: Data were obtained during 8 DEX-brief and 9 DEX-prolong procedures. In DEX-brief, HR and CI decreased (18.9 [2.3 to 35.5] bpm and 0.74 [0.15 to 1.33] L/min/m(2); respectively) at T1. There was no change in any other hemodynamic variables and all hemodynamic variables returned to baseline at recovery. In DEX-prolong, both HR and CI remained decreased (24.0 [8.3 to 39.6] bpm, 1.51 [0.95 to 2.06] L/min/m(2); respectively) at recovery. In addition, SI was decreased (8.01 [1.71 to 14.31] mL/m(2)) and SVRI was increased (776.0 [271.9 to 1280.4] dynes-sec/cm(5)/m(2)) at recovery in the DEX-prolong group. There were no significant changes in mean arterial blood pressure in either group.
CONCLUSION: DEX decreases CI in children and has a cumulative effect. For patients undergoing prolonged procedures HR and CI remained decreased at the time of discharge together with a decrease in SI and an increase in SVRI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965374     DOI: 10.1213/ANE.0b013e3182326d5a

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Changes in cardiac output and stroke volume as measured by non-invasive CO monitoring in infants with RSV bronchiolitis.

Authors:  Julie Caplow; Sarah C McBride; Garry M Steil; Jackson Wong
Journal:  J Clin Monit Comput       Date:  2012-04-24       Impact factor: 2.502

2.  Cardiac parameters in children recovered from acute illness as measured by electrical cardiometry and comparisons to the literature.

Authors:  Jackson Wong; Michael S D Agus; Garry M Steil
Journal:  J Clin Monit Comput       Date:  2012-10-06       Impact factor: 2.502

3.  Intranasal Dexmedetomidine as a Sedative for Pediatric Procedural Sedation.

Authors:  Natalie Behrle; Esma Birisci; Jordan Anderson; Sara Schroeder; Abdallah Dalabih
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

Review 4.  Anesthesia for children with mitochondrial disorders: a national survey and review.

Authors:  Muhammad B Rafique; Staci D Cameron; Qaiser Khan; Suur Biliciler; Salman Zubair
Journal:  J Anesth       Date:  2012-09-25       Impact factor: 2.078

5.  The hemodynamic response to dexmedetomidine loading dose in children with and without pulmonary hypertension.

Authors:  Robert H Friesen; Christopher S Nichols; Mark D Twite; Kathryn A Cardwell; Zhaoxing Pan; Biagio Pietra; Shelley D Miyamoto; Scott R Auerbach; Jeffrey R Darst; D Dunbar Ivy
Journal:  Anesth Analg       Date:  2013-08-19       Impact factor: 5.108

6.  Cardiac output assessed by non-invasive monitoring is associated with ECG changes in children with critical asthma.

Authors:  Jackson Wong; Kate Dorney; Megan Hannon; Garry M Steil
Journal:  J Clin Monit Comput       Date:  2013-07-20       Impact factor: 2.502

7.  Dexmedetomidine for patients undergoing diagnostic cardiac procedures: a noninferiority study.

Authors:  Nina Deutsch; Julia C Finkel; Karen Gold; Yao I Cheng; Michael C Slack; Joshua Kanter; Zenaide M N Quezado
Journal:  Pediatr Cardiol       Date:  2012-11-04       Impact factor: 1.655

8.  Dexmedetomidine versus morphine infusion following laparoscopic bariatric surgery: effect on supplemental narcotic requirement during the first 24 h.

Authors:  Sami Abu-Halaweh; Firas Obeidat; Anthony R Absalom; Abdelkareem AlOweidi; Mahmood Abu Abeeleh; Ibrahim Qudaisat; Fay Robinson; Keira P Mason
Journal:  Surg Endosc       Date:  2015-11-05       Impact factor: 4.584

9.  Results of a phase 1 multicentre investigation of dexmedetomidine bolus and infusion in corrective infant cardiac surgery.

Authors:  Athena F Zuppa; Susan C Nicolson; Nicole S Wilder; Juan C Ibla; Erin A Gottlieb; Kristin M Burns; Mario Stylianou; Felicia Trachtenberg; Hua Ni; Tera H Skeen; Dean B Andropoulos
Journal:  Br J Anaesth       Date:  2019-10-14       Impact factor: 11.719

10.  Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model.

Authors:  M Ezzati; K Broad; G Kawano; S Faulkner; J Hassell; B Fleiss; P Gressens; I Fierens; J Rostami; M Maze; J W Sleigh; B Anderson; R D Sanders; N J Robertson
Journal:  Acta Anaesthesiol Scand       Date:  2014-04-13       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.